Evidence that atypical protein kinase C-λ and atypical protein kinase C-ζ participate in Ras-mediated reorganization of the F-actin cytoskeleton
被引:127
|
作者:
Überall, F
论文数: 0引用数: 0
h-index: 0
机构:Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
Überall, F
Hellbert, K
论文数: 0引用数: 0
h-index: 0
机构:Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
Hellbert, K
Kampfer, S
论文数: 0引用数: 0
h-index: 0
机构:Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
Kampfer, S
Maly, K
论文数: 0引用数: 0
h-index: 0
机构:Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
Maly, K
Villunger, A
论文数: 0引用数: 0
h-index: 0
机构:Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
Villunger, A
Spitaler, M
论文数: 0引用数: 0
h-index: 0
机构:Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
Spitaler, M
Mwanjewe, J
论文数: 0引用数: 0
h-index: 0
机构:Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
Mwanjewe, J
Baier-Bitterlich, G
论文数: 0引用数: 0
h-index: 0
机构:Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
Baier-Bitterlich, G
Baier, G
论文数: 0引用数: 0
h-index: 0
机构:Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
Baier, G
Grunicke, HH
论文数: 0引用数: 0
h-index: 0
机构:Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
Grunicke, HH
机构:
[1] Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
[2] Univ Innsbruck, Inst Med Biol & Human Genet, A-6020 Innsbruck, Austria
来源:
JOURNAL OF CELL BIOLOGY
|
1999年
/
144卷
/
03期
关键词:
Ha-Ras L61;
atypical PKC;
F-actin;
Rac-1;
PI3K;
D O I:
10.1083/jcb.144.3.413
中图分类号:
Q2 [细胞生物学];
学科分类号:
071009 ;
090102 ;
摘要:
Expression of transforming Ha-Ras L61 in NIH3T3 cells causes profound morphological alterations which include a disassembly of actin stress fibers. The Ras-induced dissolution of actin stress fibers is blocked by the specific PKC inhibitor GF109203X at concentrations which inhibit the activity of the atypical aPKC isotypes lambda and zeta, whereas lower concentrations of the inhibitor which block conventional and novel PKC isotypes are ineffective. Coexpression of transforming Ha-Ras L61 with kinase-defective, dominant-negative (DN) mutants of aPKC-lambda and aPKC-zeta, as well as antisense constructs encoding RNA-directed against isotype-specific 5' sequences of the corresponding mRNA, abrogates the Ha-Ras-induced reorganization of the actin cytoskeleton. Expression of a kinase-defective, DN mutant of cPKC-alpha was unable to counteract Ras with regard to the dissolution of actin stress fibers. Transfection of cells with constructs encoding constitutively active (CA) mutants of atypical aPKC-lambda and aPKC-zeta lead to a disassembly of stress fibers independent of oncogenic Ha-Ras, Coexpression of (DN) Rac-1 N17 and addition of the phosphatidylinositol 3'-kinase (PI3K) inhibitors wortmannin and LY294002 are in agreement with a tentative model suggesting that, in the signaling pathway from Ha-Ras to the cytoskeleton aPKC-lambda acts upstream of PI3K and Rac-1, whereas aPKC-zeta functions downstream of PI3K and Rac-1. This model is supported by studies demonstrating that cotransfection with plasmids encoding L61Ras and either aPKC-lambda or aPKC-zeta results in a stimulation of the kinase activity of both enzymes. Furthermore, the Ras-mediated activation of PKC-zeta was abrogated by coexpression of DN Rac-1 N17.
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Lahn, M
Sundell, K
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Sundell, K
Gleave, M
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Gleave, M
Ladan, F
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Ladan, F
Su, C
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Su, C
Li, S
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Li, S
Ma, D
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Ma, D
Paterson, BM
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Paterson, BM
Bumol, TF
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA